oncology market
SGH to advance cancer treatment in new partnership
SGH to advance cancer treatment in new partnership
The collaboration will drive cord blood-derived allogeneic CAR T-cell development.
Endobronchial ultrasound biopsy devices market to reach $925.2m by 2030
It is expected to grow at a 4.3% CAGR.
Burjeel Holdings to launch radiation oncology network across GCC
The move follows an acquisition of an 80% stake in Advanced Care Oncology Centre.
Burjeel Cancer Institute launches new centre in Al Ain
The facility features dedicated chemotherapy suites and surgical oncology services.
Interventional oncology market to be valued at $4.24b by 2029
One key driver is the increasing burden of cancer.
Can Trump-backed Stargate project beat ‘The Big C’?
The tech is expected to help create a cancer vaccine in just 48 hours.
Burjeel Holdings to expand oncology care in new partnership
The initiative will focus on the development of a bone marrow transplant programme.
Australia’s oncology devices market to witness 3% CAGR until 2033
It accounted for 10% of the Asia Pacific market in 2024.
Global biopsy devices market projected to hit $4.02b by 2033
Thanks to advancements in medical technology.
Global breast cancer brachytherapy market to be valued at $1.88b by 2035
It is expected to witness a 6.94% CAGR growth during the period.
What lies ahead India’s oncology tests market?
The market faces several challenges related to access, affordability, and tech adoption.
What factors drive China’s proton therapy market?
China is expanding its network of centres across major cities.
Head and neck cancer therapeutics market to reach $4.2b by 2030
An ageing population is driving demand for advanced therapeutics.
HMC Oncology and Lymphedema Physiotherapy Department moves to QRI
The relocation features separate, dedicated therapy areas for male and female patients.
Metastatic cancer treatment market to reach $111.16b by 2027
Thanks to therapy advancements and a rise in R&D investments.
What’s driving growth in India’s oncology market?
One notable development is the use of gold nanoparticles in cancer diagnostics.
Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.
Most Read
1. Singapore launches online tool for health insurance planning 2. Medical device firms eye sustainability amidst regulatory changes 3. Japan’s medical device market to be valued at $42.9b by 2029 4. NUH, Jaga-Me ink MoU for supportive and palliative care 5. Philippine private hospitals told to avoid reckless spendingResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy